149 related articles for article (PubMed ID: 27326415)
1. Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study.
Azargoon A; Ghorbani R; Aslebahar F
Int J Reprod Biomed; 2016 May; 14(5):309-16. PubMed ID: 27326415
[TBL] [Abstract][Full Text] [Related]
2. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomised placebo-controlled double-blind trial.
Vermeulen GM; Bruinse HW
Br J Obstet Gynaecol; 1999 Jul; 106(7):652-7. PubMed ID: 10428520
[TBL] [Abstract][Full Text] [Related]
4. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
[TBL] [Abstract][Full Text] [Related]
5. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
[TBL] [Abstract][Full Text] [Related]
6. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.
da Fonseca EB; Bittar RE; Carvalho MH; Zugaib M
Am J Obstet Gynecol; 2003 Feb; 188(2):419-24. PubMed ID: 12592250
[TBL] [Abstract][Full Text] [Related]
8. Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis.
Sotiriadis A; Papatheodorou S; Makrydimas G
Ultrasound Obstet Gynecol; 2012 Sep; 40(3):257-66. PubMed ID: 22611023
[TBL] [Abstract][Full Text] [Related]
9. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study.
Brizot ML; Hernandez W; Liao AW; Bittar RE; Francisco RPV; Krebs VLJ; Zugaib M
Am J Obstet Gynecol; 2015 Jul; 213(1):82.e1-82.e9. PubMed ID: 25731690
[TBL] [Abstract][Full Text] [Related]
10. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
Conde-Agudelo A; Romero R
Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
[TBL] [Abstract][Full Text] [Related]
11. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
O'Brien JM; Adair CD; Lewis DF; Hall DR; Defranco EA; Fusey S; Soma-Pillay P; Porter K; How H; Schackis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
[TBL] [Abstract][Full Text] [Related]
12. Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial.
van Os MA; van der Ven AJ; Kleinrouweler CE; Schuit E; Kazemier BM; Verhoeven CJ; de Miranda E; van Wassenaer-Leemhuis AG; Sikkema JM; Woiski MD; Bossuyt PM; Pajkrt E; de Groot CJ; Mol BW; Haak MC
Am J Perinatol; 2015 Aug; 32(10):993-1000. PubMed ID: 25738790
[TBL] [Abstract][Full Text] [Related]
13. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M
Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
[TBL] [Abstract][Full Text] [Related]
14. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
Serra V; Perales A; Meseguer J; Parrilla JJ; Lara C; Bellver J; Grifol R; Alcover I; Sala M; Martínez-Escoriza JC; Pellicer A
BJOG; 2013 Jan; 120(1):50-7. PubMed ID: 22882759
[TBL] [Abstract][Full Text] [Related]
15. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
[TBL] [Abstract][Full Text] [Related]
16. Vaginal progesterone combined with cervical pessary: A chance for pregnancies at risk for preterm birth?
Stricker N; Timmesfeld N; Kyvernitakis I; Goerges J; Arabin B
Am J Obstet Gynecol; 2016 Jun; 214(6):739.e1-739.e10. PubMed ID: 26692180
[TBL] [Abstract][Full Text] [Related]
17. Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial.
Palacio M; Cobo T; Antolín E; Ramirez M; Cabrera F; Mozo de Rosales F; Bartha JL; Juan M; Martí A; Oros D; Rodríguez À; Scazzocchio E; Olivares JM; Varea S; Ríos J; Gratacós E;
BJOG; 2016 Nov; 123(12):1990-1999. PubMed ID: 27028759
[TBL] [Abstract][Full Text] [Related]
18. Double-blind randomized trial of progesterone to prevent preterm birth in second-trimester bleeding.
Salim R; Hakim M; Zafran N; Nachum Z; Romano S; Garmi G
Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1318-1325. PubMed ID: 31087325
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin receptor antagonists for inhibiting preterm labour.
Flenady V; Reinebrant HE; Liley HG; Tambimuttu EG; Papatsonis DN
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD004452. PubMed ID: 24903678
[TBL] [Abstract][Full Text] [Related]
20. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck TA; Miller HS; Das AF; Saade GR; Nielsen P; Baker J; Yuzko OM; Reznichenko GI; Reznichenko NY; Pekarev O; Tatarova N; Gudeman J; Birch R; Jozwiakowski MJ; Duncan M; Williams L; Krop J
Am J Perinatol; 2020 Jan; 37(2):127-136. PubMed ID: 31652479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
